Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV-Reference-Cited by-同舟云学术

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV

Published:2022-11 Issue:11 Volume:10 Page:e1549-e1550
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Vojnov Lara,Venter W D Francois

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Global tuberculosis report 2021,2021

2. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania;Zhu;Lancet Glob Health,2022

3. Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data;Ross;Lancet HIV,2021

4. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: a systematic review and meta-analysis;Uppal;PLoS Med,2021

5. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review;BMJ Open;2024-04

2. Completion of isoniazid preventive therapy for latent tuberculosis infection among children and adolescents compared to adults living with HIV in Kinshasa, Democratic Republic of the Congo;Tropical Medicine & International Health;2023-12-20

3. Exploring natural products library to identify potential inhibitors targeting isoniazid-resistant tuberculosis;Journal of Biomolecular Structure and Dynamics;2023-11-22

4. Tuberculosis–HIV co-infection in an era of complex, rapid new drug development;AIDS;2023-10-01

5. Protecting the most vulnerable: tuberculosis in immunocompromised individuals;The Challenge of Tuberculosis in the 21st Century;2023-09-01